SYN-004

· Theriva Biologics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SYN-004, covering 2017-01-11 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: SYN-004 Safety and Tolerability in Allo-HCT Subjects [Phase 1, Phase 2]